395 related articles for article (PubMed ID: 37415251)
1. The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications.
Gu Y; Fang Y; Wu X; Xu T; Hu T; Xu Y; Ma P; Wang Q; Shu Y
Exp Hematol Oncol; 2023 Jul; 12(1):58. PubMed ID: 37415251
[TBL] [Abstract][Full Text] [Related]
2. SUMOylation in Skeletal Development, Homeostasis, and Disease.
Liu H; Craig SEL; Molchanov V; Floramo JS; Zhao Y; Yang T
Cells; 2022 Aug; 11(17):. PubMed ID: 36078118
[TBL] [Abstract][Full Text] [Related]
3. The post-translational modification, SUMOylation, and cancer (Review).
Han ZJ; Feng YH; Gu BH; Li YM; Chen H
Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
[TBL] [Abstract][Full Text] [Related]
4. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer.
Xia QD; Sun JX; Xun Y; Xiao J; Liu CQ; Xu JZ; An Y; Xu MY; Liu Z; Wang SG; Hu J
Front Immunol; 2022; 13():864156. PubMed ID: 35418978
[TBL] [Abstract][Full Text] [Related]
6. The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells.
Shi X; Du Y; Li S; Wu H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408996
[TBL] [Abstract][Full Text] [Related]
7. Sumoylation in Physiology, Pathology and Therapy.
Sahin U; de Thé H; Lallemand-Breitenbach V
Cells; 2022 Feb; 11(5):. PubMed ID: 35269436
[TBL] [Abstract][Full Text] [Related]
8. Sumoylation: a regulatory protein modification in health and disease.
Flotho A; Melchior F
Annu Rev Biochem; 2013; 82():357-85. PubMed ID: 23746258
[TBL] [Abstract][Full Text] [Related]
9. The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer.
Pellegrino NE; Guven A; Gray K; Shah P; Kasture G; Nastke MD; Thakurta A; Gesta S; Vishnudas VK; Narain NR; Kiebish MA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408841
[TBL] [Abstract][Full Text] [Related]
10. Mapping the SUMOylated landscape.
Eifler K; Vertegaal AC
FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
[TBL] [Abstract][Full Text] [Related]
11. Identification of small ubiquitin-like modifier substrates with diverse functions using the Xenopus egg extract system.
Ma L; Aslanian A; Sun H; Jin M; Shi Y; Yates JR; Hunter T
Mol Cell Proteomics; 2014 Jul; 13(7):1659-75. PubMed ID: 24797264
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
Hua D; Wu X
Eur J Med Chem; 2022 Apr; 233():114227. PubMed ID: 35247754
[TBL] [Abstract][Full Text] [Related]
13. Targeting SUMOylation cascade for diabetes management.
Sireesh D; Bhakkiyalakshmi E; Ramkumar KM; Rathinakumar S; Jennifer PS; Rajaguru P; Paulmurugan R
Curr Drug Targets; 2014; 15(12):1094-106. PubMed ID: 25230117
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation homeostasis in tumorigenesis.
Xie M; Yu J; Ge S; Huang J; Fan X
Cancer Lett; 2020 Jan; 469():301-309. PubMed ID: 31705931
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment.
Chang SC; Ding JL
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):165-175. PubMed ID: 30318471
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation as a Therapeutic Target for Myocardial Infarction.
Zhao W; Zhang X; Rong J
Front Cardiovasc Med; 2021; 8():701583. PubMed ID: 34395563
[TBL] [Abstract][Full Text] [Related]
17. Targeting SUMOylation in cancer.
Du L; Liu W; Rosen ST
Curr Opin Oncol; 2021 Sep; 33(5):520-525. PubMed ID: 34280172
[TBL] [Abstract][Full Text] [Related]
18. Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer.
Zhang FL; Yang SY; Liao L; Zhang TM; Zhang YL; Hu SY; Deng L; Huang MY; Andriani L; Ma XY; Shao ZM; Li DQ
Theranostics; 2023; 13(3):973-990. PubMed ID: 36793866
[No Abstract] [Full Text] [Related]
19. Protein SUMOylation modification and its associations with disease.
Yang Y; He Y; Wang X; Liang Z; He G; Zhang P; Zhu H; Xu N; Liang S
Open Biol; 2017 Oct; 7(10):. PubMed ID: 29021212
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles of SUMO modification in arthritis.
Yan D; Davis FJ; Sharrocks AD; Im HJ
Gene; 2010 Oct; 466(1-2):1-15. PubMed ID: 20627123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
